Literature DB >> 28862119

Management of Breast Cancer Locoregional Recurrence.

Silviu Cristian Voinea, Angela Sandru, Alexandru Blidaru.   

Abstract

Breast cancer recurrence represents a challenge for clinicians because the management is not standardized and usually requires a multidisciplinary approach. This is the key for a good long term disease control and for a management with curative intent. The local recurrence in breast cancer appears after breast conserving treatment (BCT) or after mastectomy, and the regional recurrence involves the ipsilateral axillary, internal mammary or supraclavicular lymph nodes. Local recurrence prognosis after BCT seems to be better than after mastectomy regarding distant metastases occurrence and overall survival. Prognosis of axillary recurrence is better than prognosis of supraclavicular and internal mammary recurrence. Locoregional recurrence in breast cancer represents rather a marker for the appearance of distant metastases than a determinant factor for them. Management options for locoregional recurrence of cancer require multidisciplinary input decision making and for this reason the multidisciplinary tumor-board (MTD) is very important. Each patient should receive the best individualized oncologic treatment. Celsius.

Entities:  

Keywords:  locoregionalrecurrence; markerofdistantmetastases; multimodalitytreatment

Mesh:

Year:  2017        PMID: 28862119     DOI: 10.21614/chirurgia.112.4.429

Source DB:  PubMed          Journal:  Chirurgia (Bucur)        ISSN: 1221-9118


  4 in total

1.  Reirradiation of recurrent breast cancer with proton beam therapy: A case report and literature review.

Authors:  Yi-Lan Lin
Journal:  World J Clin Oncol       Date:  2019-07-24

2.  Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study.

Authors:  Yuyu Ma; Fangfang Duan; Yue Zhuang; Chenge Song; Jiajia Huang; Wen Xia; Ruoxi Hong; Qiufan Zheng; Shusen Wang; Yanxia Shi; Fei Xu; Zhongyu Yuan; Xiwen Bi
Journal:  J Oncol       Date:  2022-09-20       Impact factor: 4.501

3.  CYP19A1 gene expression in the peripheral blood of Brazilian women with breast cancer relapse.

Authors:  Maria da Conceição Barros-Oliveira; Danylo Rafhael Costa-Silva; Larysse Cardoso Campos-Verdes; Renato de Oliveira Pereira; Rozirene Araújo Silva; Paulo de Tarso Moura-Borges; Emerson Brandão Sousa; André Luiz Pinho-Sobral; Pedro Vitor Lopes-Costa; Alesse Ribeiro Dos Santos; Ione Maria Ribeiro Soares-Lopes; Jackeline Lopes Viana; Mariella de Almeida Melo; Fidelis Manes Neto; Eid Gonçalves Coelho; Maria do Socorro Pires E Cruz; Vladimir Costa-Silva; Luiz Henrique Gebrim; Benedito Borges Da Silva
Journal:  BMC Cancer       Date:  2020-05-27       Impact factor: 4.430

4.  Assessment of IGF-1 expression in the peripheral blood of women with recurrent breast cancer.

Authors:  Danylo Rafhael Costa-Silva; Maria da Conceição Barros-Oliveira; Francisco Adelton Alves-Ribeiro; Larysse Cardoso Campos-Verdes; Elmo de Jesus Nery Junior; Samara Fernanda Vieira-Valença; Rodrigo Jose de Vasconcelos-Valença; Veronica Mendes Soares; André Luiz Pinho-Sobral; Emerson Brandão Sousa; Pedro Vitor Lopes-Costa; Alesse Ribeiro Dos Santos; Jackeline Lopes Viana; Arquimedes Cavalcante Cardoso; Victoria Maria Luz-Borges; Renato de Oliveira Pereira; Cleciton Braga Tavares; Vladimir Costa Silva; Dorival Mendes Rodrigues-Junior; Luiz Henrique Gebrim; Benedito Borges da Silva
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.